EHA is proud to announce the third edition of the EHA Research Conference, titled "Transcriptional control and chromatin alterations in normal and abnormal hematopoiesis". This small, intimate and research topic-focused meeting greatly complements the much larger, wide-ranging and more clinically/translationally oriented EHA Annual Congress that takes place in June.
The meeting will be organized over 3,5 days, with significant time set aside for discussion, networking and social activities. The aim of the 2025 meeting is to present, synthesize and discuss topics related to transcriptional control and chromatin alterations in normal and abnormal hematopoiesis.
Target audience Basic or translational researcher in hematology with an interest in transcriptional control, RNA biology, chromatin architecture and regulation, epitranscriptomics and non-coding genome.
Program The program with confirmed speakers is now available; see the program page for more details.
The topics that will be covered are:
Novel RNA biology and epitranscriptomics Transcriptional control in hematopoiesis and hematological malignancies Consequences of mutations in chromatin regulators 3D chromatin architecture and nuclear organization Targeting chromatin regulators in hematology Non-coding genome Each session combines invited experts' presentations and oral abstracts based on the highest-scoring submissions. A selection of best posters will also be presented orally, as well as two dedicated poster presentation sessions.